| 2024-08-01 | +12.8% | legal | SEC EDGAR | LH 8-K: 2.02 and (SEC Filing) |
| 2025-10-28 | -10.3% | earnings | Seeking Alpha | Labcorp falls as 2025 revenue guidance midpoint lowered |
| 2025-10-28 | -10.3% | earnings | Seeking Alpha | Labcorp narrows 2025 EPS outlook, targets 8% revenue growth amid restructuring and specialty expansion |
| 2025-10-28 | -10.3% | earnings | Seeking Alpha | Labcorp Holdings Inc. (LH) Q3 2025 Earnings Call Transcript |
| 2025-10-28 | -10.3% | earnings | Seeking Alpha | Labcorp Holdings beats bottom-line estimates; updates FY outlook |
| 2025-10-28 | -10.3% | legal | SEC EDGAR | LH 8-K: 2.02 and (SEC Filing) |
| 2025-10-28 | -10.3% | news | Yahoo Finance | Here's Why Labcorp Holdings (LH) is a Strong Growth Stock - Yahoo Finance |
| 2025-10-28 | -10.3% | earnings | ChartMill | Labcorp Holdings Inc (NYSE:LH) Reports Q3 2025 Earnings Miss and Negative Market Reaction - ChartMill |
| 2025-10-28 | -10.3% | M&A | marketscreener.com | Labcorp Holdings Inc. (NYSE:LH) signed an agreement to acquire Select Assets of Empire City Laboratories, Inc. for $250 million. - marketscreener.com |
| 2025-10-27 | -8.5% | earnings | Seeking Alpha | Labcorp Holdings Q3 2025 Earnings Preview |
| 2026-01-14 | +6.1% | news | Seeking Alpha | Labcorp Holdings declares $0.72 dividend |
| 2026-01-14 | +6.1% | news | Seeking Alpha | Labcorp Holdings Inc. (LH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2026-01-14 | +6.1% | news | Stock Titan | Shareholders to get $0.72 per share as Labcorp sets March 12 dividend - Stock Titan |
| 2026-02-10 | +6.1% | earnings | TradingView | Labcorp's Q4 Earnings Preview: What's in Store for the Stock? - TradingView |
| 2026-04-09 | -5.5% | news | Seeking Alpha | Labcorp Holdings declares $0.72 dividend |
| 2026-04-09 | -5.5% | earnings | Stock Titan | Labcorp (NYSE: LH) sets $0.72 quarterly dividend payable June 11 - Stock Titan |
| 2026-04-09 | -5.5% | earnings | MarketBeat | Willis Investment Counsel Boosts Stock Holdings in Labcorp Holdings Inc. $LH - MarketBeat |
| 2026-04-09 | -5.5% | earnings | MarketBeat | Labcorp Holdings Inc. (NYSE:LH) Plans Quarterly Dividend of $0.72 - MarketBeat |
| 2026-04-09 | -5.5% | earnings | MarketBeat | Labcorp Holdings Inc. (NYSE:LH) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat |
| 2026-04-09 | -5.5% | news | Stock Titan | Labcorp shareholders get a $0.72-a-share dividend on June 11 - Stock Titan |
| 2026-01-13 | +5.3% | news | Stock Titan | Blood test from Labcorp spots breast, lung and colon cancer earlier - Stock Titan |
| 2025-07-24 | +5.3% | earnings | Seeking Alpha | Labcorp Holdings Inc. 2025 Q2 - Results - Earnings Call Presentation |
| 2025-07-24 | +5.3% | earnings | Seeking Alpha | Labcorp Holdings Inc. (LH) Q2 2025 Earnings Call Transcript |
| 2025-07-24 | +5.3% | earnings | Seeking Alpha | Labcorp Holdings Non-GAAP EPS of $4.35 beats by $0.19, revenue of $3.53B beats by $40M |
| 2025-07-24 | +5.3% | legal | SEC EDGAR | LH 8-K: 2.02 and (SEC Filing) |
| 2025-07-23 | +5.3% | earnings | Seeking Alpha | Labcorp Holdings Q2 2025 Earnings Preview |
| 2024-02-15 | -5.2% | legal | SEC EDGAR | LH 8-K: 2.02 and (SEC Filing) |
| 2024-04-25 | -5.2% | legal | SEC EDGAR | LH 8-K: 2.02 and (SEC Filing) |
| 2023-02-16 | +4.9% | legal | SEC EDGAR | LH 8-K: 2.02 and (SEC Filing) |
| 2025-04-29 | +4.3% | earnings | Seeking Alpha | Labcorp targets 10% EPS growth with new diagnostics and acquisitions strategy |
| 2025-04-29 | +4.3% | earnings | Seeking Alpha | Labcorp Holdings Inc. (LH) Q1 2025 Earnings Call Transcript |
| 2025-04-29 | +4.3% | legal | SEC EDGAR | LH 8-K: 2.02 and (SEC Filing) |
| 2022-10-27 | -4.3% | legal | SEC EDGAR | LH 8-K: 2.02 and (SEC Filing) |
| 2026-04-10 | -4.2% | legal | Stock Titan | [ARS] LABCORP HOLDINGS INC. SEC Filing - Stock Titan |
| 2026-04-10 | -4.2% | legal | Stock Titan | Labcorp Holdings Inc SEC Filings - Stock Titan |
| 2025-11-07 | +4.2% | earnings | simplywall.st | The Strong Earnings Posted By Labcorp Holdings (NYSE:LH) Are A Good Indication Of The Strength Of The Business - simplywall.st |
| 2024-10-24 | +3.8% | legal | SEC EDGAR | LH 8-K: 2.02 and (SEC Filing) |
| 2022-04-28 | -3.8% | legal | SEC EDGAR | LH 8-K: 2.02 and (SEC Filing) |
| 2026-04-22 | -3.7% | news | StockStory | 2 of Wall Street’s Favorite Stocks to Consider Right Now and 1 We Question |
| 2026-04-22 | -3.7% | news | MT Newswires | Labcorp Rolls Out Companion Diagnostic for Merck's Keytruda in Platinum-Resistant Ovarian Cancer |
| 2026-04-22 | -3.7% | expansion | PR Newswire | Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients with Ovarian Cancer Eligible for KEYTRUDA® |
| 2026-04-22 | -3.7% | earnings | Cổng thông tin điện tử tỉnh Tây Ninh | LH (Labcorp Holdings Inc.) delivers 7.2% YoY Q4 2025 revenue growth and small EPS beat, shares edge down 0.8%. - Expert Stock Picks - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-04-23 | -3.6% | earnings | Zacks | Labcorp Holdings (LH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release |
| 2026-04-23 | -3.6% | earnings | Xã Thanh Hà | Labcorp Holdings (LH) Stock Movers | Labcorp Holdings Inc notches 0.3% EPS beat, solid revenue - Liquidity Risk - Xã Thanh Hà |
| 2025-07-10 | -3.6% | news | Seeking Alpha | Labcorp Holdings declares $0.72 dividend |
| 2024-05-17 | -3.2% | legal | SEC EDGAR | LH 8-K: 1.01, 2.03, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01 (SEC Filing) |
| 2025-10-30 | +3.1% | earnings | Yahoo Finance | Labcorp Holdings Inc (LH) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance |
| 2026-03-26 | +2.8% | news | Stock Titan | Vanguard realigns reporting; Vanguard (LH) amendment shows 0 shares - Stock Titan |
| 2023-04-25 | -2.6% | legal | SEC EDGAR | LH 8-K: 2.02 and (SEC Filing) |
| 2025-10-23 | -2.6% | news | Seeking Alpha | Labcorp to offer Roche, Lilly Alzheimer's blood test starting in early 2026 |
| 2025-08-18 | +2.6% | expansion | Seeking Alpha | Labcorp launches FDA-cleared blood test for Alzheimer's disease |
| 2024-09-18 | -2.5% | legal | SEC EDGAR | LH 8-K: 8.01 and (SEC Filing) |
| 2026-02-24 | -2.5% | legal | TradingView | LABCORP HOLDINGS INC. SEC 10-K Report - TradingView |
| 2026-02-09 | +2.4% | legal | SEC EDGAR | LH 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-02-09 | +2.4% | news | Yahoo Finance | Labcorp Holdings (NYSE:LH) Has Announced A Dividend Of $0.72 - Yahoo Finance |
| 2026-02-09 | +2.4% | news | Stock Titan | Top neurosurgeon and med school dean joins Labcorp board - Stock Titan |
| 2022-07-28 | +2.4% | legal | SEC EDGAR | LH 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-10-26 | +2.3% | legal | SEC EDGAR | LH 8-K: 2.02 and (SEC Filing) |
| 2023-07-27 | -2.2% | legal | SEC EDGAR | LH 8-K: 2.02 and (SEC Filing) |
| 2026-01-17 | +2.2% | news | Yahoo Finance | Labcorp Holdings (NYSE:LH) Has Announced A Dividend Of $0.72 - Yahoo Finance |
| 2026-03-25 | +2.1% | news | Fortune | Labcorp Holdings (LH): Company Profile, Stock Price, News, Rankings - Fortune |
| 2023-05-04 | -2.1% | legal | SEC EDGAR | LH 8-K: 5.02 (SEC Filing) |
| 2025-09-09 | -2.1% | news | Seeking Alpha | Labcorp Holdings Inc. (LH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript |
| 2026-02-17 | -2.0% | earnings | Seeking Alpha | Labcorp outlines 5.4% midpoint revenue growth and 9% EPS target for 2026 while advancing specialty and AI initiatives |
| 2026-02-17 | -2.0% | earnings | Seeking Alpha | Labcorp Holdings Inc. (LH) Q4 2025 Earnings Call Transcript |
| 2026-02-17 | -2.0% | earnings | Seeking Alpha | Labcorp slips after Q4 revenue miss |
| 2026-02-17 | -2.0% | earnings | Seeking Alpha | Labcorp Holdings Inc. 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-17 | -2.0% | news | Seeking Alpha | Labcorp Holdings reports mixed results; initiates FY26 outlook |
| 2026-02-17 | -2.0% | legal | SEC EDGAR | LH 8-K: 2.02 and (SEC Filing) |
| 2026-02-17 | -2.0% | news | PR Newswire | Labcorp Announces 2025 Fourth Quarter and Full Year Results - PR Newswire |
| 2026-02-17 | -2.0% | earnings | Seeking Alpha | Labcorp stock slips after Q4 revenue miss (LH:NYSE) - Seeking Alpha |
| 2026-02-17 | -2.0% | earnings | TradingView | Labcorp Q4 Earnings Beat, Revenues Miss, Stock Down in Pre-Market - TradingView |
| 2026-02-17 | -2.0% | earnings | marketscreener.com | Labcorp Holdings Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com |
| 2025-09-30 | -2.0% | news | Seeking Alpha | Labcorp partners with Roche to advance digital pathology and AI integration |
| 2025-10-14 | +1.9% | news | Yahoo Finance | Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term - Yahoo Finance |
| 2026-02-23 | +1.9% | expansion | Seeking Alpha | Labcorp expands PathAI partnership to deploy digital pathology platform nationwide |
| 2026-02-23 | +1.9% | news | DirectorsTalk Interviews | Labcorp Holdings Inc. (LH) Stock Analysis: A Promising 8.21% Potential Upside for Investors - DirectorsTalk Interviews |
| 2026-02-23 | +1.9% | news | Stock Titan | AI reads lab slides: Labcorp takes digital pathology nationwide - Stock Titan |
| 2025-12-15 | -1.9% | legal | SEC EDGAR | LH 8-K: 5.02 (SEC Filing) |
| 2026-04-20 | +1.9% | news | DirectorsTalk Interviews | Labcorp Holdings Inc. (LH) Stock Analysis: Evaluating a 14.55% Potential Upside for Investors - DirectorsTalk Interviews |
| 2026-02-18 | +1.9% | analyst | GuruFocus | JP Morgan Raises Price Target for Labcorp Hldgs (LH) to $330.00 - GuruFocus |
| 2022-02-10 | +1.8% | legal | SEC EDGAR | LH 8-K: 2.02 and (SEC Filing) |
| 2026-01-29 | +1.8% | legal | SEC EDGAR | LH 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-11-06 | +1.8% | news | simplywall.st | Independent Director Of Labcorp Holdings Sold 74% Of Their Shares - simplywall.st |
| 2025-11-19 | +1.8% | news | Stock Titan | Labcorp (NYSE: LH) Plasma Detect MRD Studies Highlight ctDNA Monitoring in Cancer - Stock Titan |
| 2026-03-03 | -1.8% | news | Stock Titan | Labcorp (NYSE: LH) EVP reports open-market insider stock sale - Stock Titan |
| 2026-04-01 | +1.7% | earnings | MarketBeat | Assenagon Asset Management S.A. Sells 32,625 Shares of Labcorp Holdings Inc. $LH - MarketBeat |
| 2025-12-10 | +1.7% | legal | SEC EDGAR | LH 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-10-31 | +1.7% | analyst | simplywall.st | The Labcorp Holdings Inc. (NYSE:LH) Third-Quarter Results Are Out And Analysts Have Published New Forecasts - simplywall.st |
| 2026-04-08 | -1.6% | earnings | MarketBeat | Raleigh Capital Management Inc. Sells 11,248 Shares of Labcorp Holdings Inc. $LH - MarketBeat |
| 2026-03-30 | -1.6% | news | Stock Titan | Labcorp (LH) EVP granted 6,604 shares; 2,879 withheld for tax - Stock Titan |
| 2026-03-30 | -1.6% | executive | Stock Titan | Labcorp (NYSE: LH) CEO receives 58,470-share award, 26,106 withheld for taxes - Stock Titan |
| 2026-03-30 | -1.6% | news | Stock Titan | Labcorp (LH) EVP Bailey granted 1,184 shares, 481 withheld for taxes - Stock Titan |
| 2026-03-30 | -1.6% | news | Stock Titan | Labcorp (LH) CLO awarded 1,584 shares; 451 withheld for tax - Stock Titan |
| 2026-03-30 | -1.6% | news | Stock Titan | Labcorp (NYSE: LH) EVP gets 6,382-share award, 2,722 shares withheld for tax - Stock Titan |
| 2026-03-30 | -1.6% | news | Stock Titan | Labcorp (NYSE: LH) EVP granted performance stock; shares withheld for tax - Stock Titan |
| 2026-03-30 | -1.6% | news | Stock Titan | Labcorp (LH) EVP gets performance shares, sells portion under 10b5-1 plan - Stock Titan |
| 2026-03-30 | -1.6% | news | Stock Titan | Labcorp (NYSE: LH) SVP sells shares after award under Rule 10b5-1 - Stock Titan |
| 2026-03-30 | -1.6% | news | Stock Titan | Labcorp (LH) EVP gets 1,584-share award, 451 withheld for taxes - Stock Titan |
| 2026-03-30 | -1.6% | news | Stock Titan | Labcorp (NYSE: LH) EVP granted 1,340 shares; 382 withheld for taxes - Stock Titan |
| 2022-10-13 | +1.6% | legal | SEC EDGAR | LH 8-K: 5.02, 7.01 (SEC Filing) |
| 2023-05-05 | -1.5% | legal | SEC EDGAR | LH 8-K: 5.02 (SEC Filing) |
| 2025-05-20 | -1.4% | legal | SEC EDGAR | LH 8-K: 5.02, 5.07 (SEC Filing) |
| 2026-03-16 | +1.3% | news | DirectorsTalk Interviews | Labcorp Holdings Inc. (LH) Stock Analysis: Exploring A 16.64% Potential Upside - DirectorsTalk Interviews |
| 2026-03-02 | -1.3% | analyst | DirectorsTalk Interviews | Labcorp Holdings Inc. (LH) Stock Analysis: Strong Buy Ratings and Strategic Expansion Drive Investor Interest - DirectorsTalk Interviews |
| 2024-09-23 | -1.3% | legal | SEC EDGAR | LH 8-K: 1.01 and (SEC Filing) |
| 2025-06-27 | +1.2% | news | Seeking Alpha | Exas, Guardant, Gilead among gainers as Supreme Court ensures free preventive care |
| 2025-06-27 | +1.2% | legal | SEC EDGAR | LH 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-02-13 | +1.2% | news | Seeking Alpha | Labcorp Holdings: Focus On Core Strengths For Future Growth, Initiate At 'Hold' (NYSE:LH) - Seeking Alpha |
| 2023-07-03 | +1.1% | legal | SEC EDGAR | LH 8-K: 1.01, 2.01, 8.01 (SEC Filing) |
| 2026-04-14 | -1.1% | earnings | MarketBeat | Labcorp Holdings Inc. $LH Shares Sold by AMI Asset Management Corp - MarketBeat |
| 2023-06-07 | +1.0% | legal | SEC EDGAR | LH 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-09-22 | +1.0% | analyst | Yahoo Finance | Labcorp Holdings Stock: Is LH Outperforming the Healthcare Sector? - Yahoo Finance |
| 2025-11-21 | -1.0% | news | simplywall.st | There's A Lot To Like About Labcorp Holdings' (NYSE:LH) Upcoming US$0.72 Dividend - simplywall.st |
| 2026-03-01 | -1.0% | earnings | Yahoo Finance | Did Labcorp’s 2026 Revenue Outlook and Buybacks Just Reframe Labcorp Holdings' (LH) Investment Narrative? - Yahoo Finance |
| 2025-10-08 | -1.0% | news | Seeking Alpha | Labcorp Holdings declares $0.72 dividend |
| 2025-06-30 | +1.0% | analyst | Seeking Alpha | Labcorp Upgraded To A Buy As Portfolio Grows And Leverage Stays Low |
| 2023-09-11 | -1.0% | legal | SEC EDGAR | LH 8-K: 5.02 (SEC Filing) |
| 2026-02-19 | +0.9% | news | Yahoo Finance | Labcorp Holdings Stock: Is Wall Street Bullish or Bearish? - Yahoo Finance |
| 2026-04-21 | +0.9% | news | StockStory | 1 S&P 500 Stock to Research Further and 2 We Find Risky |
| 2026-04-21 | +0.9% | analyst | Zacks | All You Need to Know About Labcorp (LH) Rating Upgrade to Buy |
| 2026-04-21 | +0.9% | news | Zacks | LH or DHR: Which Is the Better Value Stock Right Now? |
| 2026-04-21 | +0.9% | earnings | Zacks | Labcorp Gears Up to Report Q1 Earnings: What's in Store? |
| 2026-04-21 | +0.9% | earnings | TradingView | Labcorp Gears Up to Report Q1 Earnings: What's in Store? - TradingView |
| 2025-02-06 | -0.9% | legal | SEC EDGAR | LH 8-K: 2.02 and (SEC Filing) |
| 2025-11-24 | -0.8% | legal | SEC EDGAR | LH 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-11-24 | -0.8% | news | Stock Titan | Labcorp (NYSE: LH) adds Novartis leader Victor Bulto, overseeing $20B+ U.S. unit on Board - Stock Titan |
| 2023-12-13 | +0.8% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2024-08-23 | -0.8% | legal | SEC EDGAR | LH 8-K: 1.01, 2.03 (SEC Filing) |
| 2026-03-20 | +0.8% | legal | SEC EDGAR | LH 8-K: 1.01, 2.03 (SEC Filing) |
| 2026-03-20 | +0.8% | legal | Stock Titan | Labcorp (NYSE: LH) secures $750M unsecured term loan due 2028 - Stock Titan |
| 2025-09-17 | +0.8% | news | Seeking Alpha | Labcorp Holdings: Currently Priced For Cash And Growth |
| 2026-02-13 | -0.7% | earnings | Seeking Alpha | Labcorp Holdings Q4 2025 Earnings Preview |
| 2024-11-19 | -0.7% | legal | SEC EDGAR | LH 8-K: 5.02, 7.01 (SEC Filing) |
| 2021-07-31 | +0.7% | earnings | Zacks Investment Research | What date does Labcorp Holdings Inc.'s (LH) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research |
| 2026-02-11 | -0.7% | earnings | Finviz | Will Labcorp (LH) Beat Estimates Again in Its Next Earnings Report? - Finviz |
| 2026-02-11 | -0.7% | news | simplywall.st | Labcorp Holdings (NYSE:LH) Has Announced A Dividend Of $0.72 - simplywall.st |
| 2026-02-11 | -0.7% | news | Stock Titan | New Alzheimer's blood test lets family doctors rule out disease - Stock Titan |
| 2025-05-08 | -0.6% | executive | simplywall.st | Most Shareholders Will Probably Agree With Labcorp Holdings Inc.'s (NYSE:LH) CEO Compensation - simplywall.st |
| 2025-09-16 | +0.5% | news | Yahoo Finance | Here's Why Labcorp Holdings (LH) is a Strong Growth Stock - Yahoo Finance |
| 2025-09-16 | +0.5% | earnings | simplywall.st | Investors Interested In Labcorp Holdings Inc.'s (NYSE:LH) Earnings - simplywall.st |
| 2026-04-19 | -0.4% | earnings | MarketBeat | Birch Hill Investment Advisors LLC Sells 37,071 Shares of Labcorp Holdings Inc. $LH - MarketBeat |
| 2026-04-18 | -0.4% | earnings | MarketBeat | Labcorp Holdings Inc. $LH Stake Boosted by KBC Group NV - MarketBeat |
| 2025-01-31 | -0.3% | legal | SEC EDGAR | LH 8-K: 1.01, 2.03 (SEC Filing) |
| 2023-01-05 | +0.3% | legal | SEC EDGAR | LH 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-03-27 | +0.3% | news | AD HOC NEWS | Labcorp Holdings Stock: Business Model, Market Position and Investor Considerations for US50540R4092 - AD HOC NEWS |
| 2026-03-31 | -0.2% | earnings | Stock Titan | Labcorp (NYSE: LH) schedules Q1 2026 earnings release and webcast - Stock Titan |
| 2026-03-31 | -0.2% | news | Stock Titan | Labcorp will post first-quarter results before markets open April 30 - Stock Titan |
| 2026-03-29 | +0.1% | earnings | MarketBeat | Hunter Perkins Capital Management LLC Has $24.11 Million Stock Position in Labcorp Holdings Inc. $LH - MarketBeat |
| 2025-02-02 | -0.1% | news | Intellectia AI | LH Forecast — Price Prediction for 2026. Should I Buy LH? - Intellectia AI |
| 2026-04-17 | +0.1% | news | PR Newswire | Ultima Genomics releases groundbreaking TRACERx MRD data showing ppmSeq performance and unveils clinical progress of whole genome sequencing at inaugural global MRD Symposium at AACR 2026 |
| 2026-01-06 | -0.1% | news | TradingView | Should Labcorp Stock Stay in Your Portfolio Right Now? - TradingView |
| 2026-04-16 | +0.0% | earnings | MarketBeat | Sumitomo Mitsui Trust Group Inc. Sells 28,674 Shares of Labcorp Holdings Inc. $LH - MarketBeat |
| 2026-04-25 | — | earnings | MarketBeat | Universal Beteiligungs und Servicegesellschaft mbH Has $24.01 Million Stock Position in Labcorp Holdings Inc. $LH - MarketBeat |
| 2026-04-24 | — | M&A | TMX Newsfile | SureNano Science Initiates FDA Stage GLP Toxicology and Pharmacology Studies for GLP GEP-44 and Enters Discussions to Acquire Ibogaine Formulation IP Portfolio |